Bayer begins Phase III programme of vilaprisan to treat uterine fibroids

Bayer has started a Phase III ASTEROID clinical programme of vilaprisan with enrolment of the first patient for treatment of uterine fibroids.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news
More News: